Prognostic Factors and Clinical Features of Non-typhoid Salmonella Bacteremia in Adults  by Yen, Yung-Fong et al.
J Chin Med Assoc • August 2009 • Vol 72 • No 8408
© 2009 Elsevier. All rights reserved.
Introduction
In developing countries, non-typhoid Salmonella (NTS)
accounts for a steadily increasing proportion of human
infections in recent decades.1 Most patients with NTS
infection have self-limited gastroenteritis, but invasive
diseases with bacteremia are found in 5% of patients,2
especially in renal transplant recipients,3 patients with
acquired immunodeficiency syndrome (AIDS),4–6 sys-
temic lupus erythematous (SLE),6,7 diabetes mellitus
(DM)6 and malignant diseases.8 Antibiotic treatment is
very important in cases with invasive diseases or com-
plicated bacteremia, but the prevalence of multidrug-
resistant NTS bacteremia in adult patients has gradually
increased in the last decade, which has made the treat-
ment of invasive salmonellosis a clinical dilemma.9–11
In related literature, very few studies have focused
on analyzing the prognostic factors in NTS bacteremia.
In this study, we collected 71 cases of NTS bacteremia
to analyze the prognostic factors and clinical features.
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Methods
All adult patients, older than 18 years, admitted during
the study period (January 2004 to December 2006)
to the hospital were considered eligible if they had had
at least 1 blood set positive for NTS. The hospital is 
a 2,900-bed tertiary referral medical center and has spe-
cialized units for solid organ and bone marrow trans-
plantation, cardiac monitoring, burns and intensive care
units. The medical records of eligible patients were
reviewed, including their demographic characteristics,
underlying diseases, clinical presentations, use of ste-
roids, bacteriological characteristics, antibiotic suscep-
tibility, treatment and outcome.
Steroid use was defined as having taken 30 mg
prednisone daily (or an equivalent dosage) for at least
1 week or 20 mg prednisone daily for at least 2 weeks
before the positive blood sample was drawn. Patients
were considered to be immunosuppressed in the pres-
ence of any of the following conditions: collagen dis-
ease, liver cirrhosis, malignancy, organ transplantation,
steroid use, or AIDS. A white blood cell count of
< 4 × 109/L was classified as leukopenia.
Complications due to NTS bacteremia (i.e. acute
respiratory failure, shock, coma) were defined as follows.
Acute respiratory failure was defined as the development
of hypoxia (PaO2 < 60 mmHg) and/or hypercapnia
(PaCO2 > 50 mmHg) in room air, and was considered
to be bacteremia-related if no other obvious cause was
found. Shock was defined as systolic blood pressure
< 90 mmHg and/or if total urine output was < 80 mL
over a period of 4 hours, and was considered to be
bacteremia-related (septic shock) if there was no other
obvious cause. Coma was defined as the presence of
impaired responsiveness (or unresponsiveness) to exter-
nal stimulation and the patient was difficult to arouse
or unarouseable.12
Cure was defined as the disappearance of clinical
symptoms and signs as well as negativity of blood cul-
tures posttreatment. Thirty-day mortality was defined
as death occurring within 30 days of septicemia.
Any microbiologically or clinically documented in-
fection was considered to be septic metastasis due to
NTS if it developed ≥ 2 days after the first positive
blood sample was drawn. Inadequate antibiotic therapy
was defined as either (1) the antibiotic was not sensi-
tive to Salmonella species isolated from blood culture
or (2) the antibiotic had not been proven to have good
penetration into cells.
NTS isolates were identified by serotyping according
to the Kauffmann-White scheme utilizing Salmonella
agglutination antisera. In vitro activities to various anti-
microbials were determined by measuring minimum
inhibitory concentrations (MICs) using agar dilution
methods (Clinical and Laboratory Standards Institute,
2006),13 and susceptible or resistant isolates were de-
fined according to the criteria suggested by the Clinical
and Laboratory Standards Institute.14
Univariate analysis was used to identify the risk
factors associated with the outcome of salmonellosis.
Fisher’s exact or χ2 test was used for the comparison
of proportions. SPSS version 15.0 (SPSS Inc., Chicago,
IL, USA) for Windows was used for the statistical
analysis of odds ratios and 95% confidence intervals.
A p value < 0.05 was considered significant.
Multiple logistic regression analysis was used to
evaluate the relationship between patients’ character-
istics and all other covariates studied for prognosis.
We built the model using a stepwise selection strategy,
and the covariates that were found to be significant
(p < 0.05) were included in the final model.
Results
During the 3-year period, a total of 71 cases of NTS
were collected. Forty-eight (67.6%) patients were males.
The mean age was 60 years (range, 24–93 years).
Underlying diseases were identified in 46 (64.8%) cases
(Table 1). The most common underlying disease was
solid tumor (18 cases, 25.4%), followed by DM (16
cases, 22.5%), AIDS (9 cases, 12.7%) and SLE (5 cases,
7.0%).
Fifty-eight (81.7%) cases manifested with fever, and
16 (22.5%) cases were accompanied or preceded by
symptoms of acute gastroenteritis. Eight (11.3%) cases
presented with septic metastases including osteomye-
litis (2 cases), central nervous system infection (1 case),
mycotic aneurysm (4 cases), and soft tissue infection
(1 case).
Salmonella enteritidis was isolated in 30 (42.3%)
cases, Salmonella typhimurium in 22 (31.0%), and
Salmonella choleraesuis in 19 (26.7%).
In vitro activities are shown in Table 2. Thirty-two
(45.1%) isolates were susceptible to chloramphenicol,
37 (52.1%) to ampicillin, 47 (66.2%) to trimethoprim/
sulfamethoxazole (TMP/SMX), 56 (78.9%) to moxi-
floxacin, 57 (80.3%) to ciprofloxacin and levofloxacin,
and 71 (100%) to ceftriaxone.
The crude 30-day mortality rate was 19.7% (Table
1). The clinical, epidemiological and laboratory vari-
ables, and the underlying diseases studied and their
relative influence on mortality are shown in Table 3.
Age ≥ 65 years, immunosuppressed status, septic shock,
coma, acute respiratory failure and inadequate anti-
biotic treatment were significantly associated with high
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mortality. Values for all variables were available in all
episodes and were included in the logistic regression
analysis. Coma and inadequate antibiotic treatment
were identified as independent risk factors for outcome
(Table 4).
Discussion
Most previously reported cases of NTS bacteremia in
adults were described as having symptoms of gastro-
enteritis not developed at presentation.8 Sixteen (22.5%)
cases presented with symptoms of gastroenteritis in
this study. The rate of septic metastasis of 11.3% in
our series was similar to the 15.7% and 12.5% in earlier
reports.15,16 Four cases with S. choleraesuis developed
the complication of mycotic aneurysm in this study.
This serious complication often occurs in elderly or
arteriosclerotic patients with salmonellosis, particularly
in S. choleraesuis bacteremia.17–19
It is well documented that certain patient groups are
at increased risk of acquiring NTS bacteremia.3–8 In
our study, 64.8% of patients had underlying diseases,
including malignant diseases, DM, AIDS, and SLE.
Table 1. Characteristics of 71 cases of non-typhoid Salmonella bacteremia
Serotype
S. typhimurium S. choleraesuis S. enteritidis
n (%)
Number of cases 22 19 30 71 (100)
Male 13 16 19 48 (67.6)
Mean age (yr) 60 60 62 60
Age range (yr) 32–80 32–89 24–93 24–93
Age ≥ 65 yr 13 9 9 31 (43.7)
Clinical presentations
Diarrhea 4 5 7 16 (22.5)
Fever 18 16 24 58 (81.7)
Septic metastasis* 1 4 3 8 (11.3)
Steroid use 5 1 7 13 (18.3)
Underlying diseases
Solid tumor 6 2 10 18 (25.4)
Diabetes mellitus 11 0 5 16 (22.5)
AIDS 2 4 3 9 (12.7)
SLE 2 0 3 5 (7.0)
Hematological malignancy 1 1 2 4 (5.6)
Organ transplantation 0 1 0 1 (1.4)
None 7 10 8 25 (35.2)
Deaths (within 30 d) 6 4 4 14 (19.7)
*Includes osteomyelitis (2 cases), central nervous system infection (1 case), mycotic aneurysm (4 cases), and soft tissue infection (1 case). AIDS = acquired
immunodeficiency syndrome; SLE = systemic lupus erythematous.
Table 2. Antimicrobial susceptibility of 71 isolates of non-typhoid Salmonella bacteremia
MIC (mg/L)
Range MIC50 MIC90
Percentage of 
isolates susceptible
Ampicillin 1 to > 128 4 > 128 52.1
TMP/SMX 0.06 to > 128 0.25 > 128 66.2
Chloramphenicol 4 to > 128 32 > 128 45.1
Ceftriaxone 0.03 to 0.5 0.12 0.12 100
Ciprofloxacin 0.015 to 16 0.03 16 80.3
Levofloxacin < 0.015 to 16 0.12 16 80.3
Moxifloxacin < 0.015 to 32 0.12 16 78.9
MIC = minimum inhibitory concentration; TMP/SMX = trimethoprim/sulfamethoxazole.
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S. enteritidis and S. typhimurium contributing to
over 75% of all NTS infections have been reported,20
and certain serotypes such as S. choleraesuis21 and 
S. virchow22 have also been reported to be associated
with a higher incidence of septicemia. In this study,
the most commonly isolated serotype was S. enteritidis,
followed by S. typhimurium and S. choleraesuis.
Resistance of NTS to some common antimicrobials
(ampicillin, chloramphenicol, TMP/SMX) has been
increasing gradually.23 Our study also found poor sus-
ceptibility to chloramphenicol, ampicillin, and TMP/
SMX. Isolates of fluoroquinolone-resistant Salmonella
have increased steadily in the last decade.24–29 In our
study, 14 (19.7%) isolates were resistant to ciprofloxacin
Table 3. Univariate analysis of risk factors influencing the outcome in 71 cases of non-typhoid Salmonella bacteremia
No. of patients who 
OR (95% CI) p
died/total no.
Sex
Male 11/48 1.98 (0.50–7.94) 0.328
Female 3/23 1
Age (yr)
≥ 65 11/31 6.78 (1.69–27.17) 0.003
< 65 3/40 1
Fever
Yes 11/58 0.78 (0.18–3.32) 0.736
No 3/13 1
Leukocyte count (109/L)
< 4 5/17 2.08 (0.59–7.38) 0.249
≥ 4 9/54 1
Septic metastasis
Yes 1/8 0.55 (0.06–4.87) 0.586
No 13/63 1
Immunosuppressed
Yes 12/41 5.79 (1.19–28.25) 0.018
No 2/30 1
Septic shock
Yes 7/13 8.50 (2.21–32.67) 0.001
No 7/58 1
Coma
Yes 7/12 10.40 (2.58–41.87) < 0.001
No 7/59 1
Acute respiratory failure
Yes 6/11 7.80 (1.92–31.66) 0.002
No 8/60 1
Inadequate antibiotic treatment
Yes 6/12 6.38 (1.64–24.71) 0.004
No 8/59 1
OR = odds ratio; CI = confidence interval.
Table 4. Multivariate logistic regression model for the analysis of factors predicting prognosis in 71 episodes of non-typhoid
Salmonella bacteremia
High-risk category OR of death (95% CI) p
Coma Present 12.03 (2.59–55.89) 0.002
Inadequate antibiotic treatment Present 7.63 (1.60–36.30) 0.011
OR = odds ratio; CI = confidence interval.
and levofloxacin and 15 (21.1%) to moxifloxacin. Addi-
tionally, the MIC90 of fluoroquinolones in this study
was high. According to previous reports,30,31 Salmonella
species have excellent sensitivities to third-generation
cephalosporins, including ceftriaxone. In our study,
all NTS isolates were susceptible to ceftriaxone.
Coma, immunosuppressed status and septic shock
were independent risk factors of death in a previous
study.16 In this study, a patient was more likely to die
of Salmonella bacteremia when they had ≥ 1 of the
following factors: age ≥ 65 years, immunosuppressed
status, inadequate antibiotic treatment, and presence
of septic shock, coma or acute respiratory failure. Coma
and inadequate antibiotic treatment were identified as
independently influencing prognosis.
In conclusion, most cases of NTS bacteremia in
adults did not have the presenting symptoms of gas-
troenteritis. S. enteritidis was the most frequently iso-
lated serotype. A high rate of NTS resistant to some
readily available antimicrobials (ampicillin, chloram-
phenicol, TMP/SMX, fluoroquinolones) was found.
Patients with coma or inadequate antibiotic treatment
had poor outcome.
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